Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H17N3S |
| Molecular Weight | 282.392 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN([11CH3])CC1=C(SC2=CC=C(C=C2N)C#N)C=CC=C1
InChI
InChIKey=UVWLEPXXYOYDGR-BJUDXGSMSA-N
InChI=1S/C16H17N3S/c1-19(2)11-13-5-3-4-6-15(13)20-16-8-7-12(10-17)9-14(16)18/h3-9H,11,18H2,1-2H3/i1-1
| Molecular Formula | C16H17N3S |
| Molecular Weight | 282.392 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
3-amino-4-(2[11C]methylaminomethylphenylsulfanyl)benzonitrile (DASB C-11) exhibits excellent in vitro and in vivo properties toward the serotonin transporter. Parametric imaging of serotonin transporters (SERT) with DASB C-11 PET is a useful data analysis tool. DASB C-11 is a suitable PET radioligand for measuring drug occupancy of the SERT in vivo and has potential for monitoring in vivo changes in serotonin levels. Studies in humans showed that the regional distribution of DASB C-11 uptake was concordant with the known densities of SERT sites in the brain. The highest levels of radioactivity were observed in the hypothalamus, intermediate levels were observed in the thalamus and striatum, whereas modest to low levels of radioactivity were observed in the cortical regions and cerebellum, respectively.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 3-Amino-4-(2-((4-[18F]fluorobenzyl)methylamino)methylphenylsulfanyl)benzonitrile, an F-18 fluorobenzyl analogue of DASB: synthesis, in vitro binding, and in vivo biodistribution studies. | 2007-08-21 |
|
| PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. | 2006-02 |
|
| [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. | 2003-02 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:07:45 GMT 2025
by
admin
on
Mon Mar 31 18:07:45 GMT 2025
|
| Record UNII |
FJU46Q2BPU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
656408
Created by
admin on Mon Mar 31 18:07:45 GMT 2025 , Edited by admin on Mon Mar 31 18:07:45 GMT 2025
|
PRIMARY | |||
|
FJU46Q2BPU
Created by
admin on Mon Mar 31 18:07:45 GMT 2025 , Edited by admin on Mon Mar 31 18:07:45 GMT 2025
|
PRIMARY | |||
|
296774-13-5
Created by
admin on Mon Mar 31 18:07:45 GMT 2025 , Edited by admin on Mon Mar 31 18:07:45 GMT 2025
|
PRIMARY | |||
|
DTXSID601319129
Created by
admin on Mon Mar 31 18:07:45 GMT 2025 , Edited by admin on Mon Mar 31 18:07:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
||
|
RADIOLIGAND->TARGET |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| VOLUME OF DISTRIBUTION | PHARMACOKINETIC |
|
|
|||